Cancer and the microbiota
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
A host’s microbiota may increase, diminish, or have no effect at all on cancer susceptibility. Assigning causal roles in cancer to specific microbes and microbiotas, unraveling host-microbiota interactions with environmental factors in carcinogenesis, and exploiting such knowledge for cancer diagnosis and treatment are areas of intensive interest. This Review considers how microbes and the microbiota may amplify or mitigate carcinogenesis, responsiveness to cancer therapeutics, and cancer-associated complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss of microbial diversity (dysbiosis) is associated with chronic health conditions (26–28) and cancer (8–10), and is also associated with poor outcomes to certain forms of cancer therapy including allogeneic stem cell transplant (29).”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [8]
In the citing paper
“It has recently emerged that factors beyond tumor genomics influence cancer development and therapeutic responses (4–7), including host factors such as the gastrointestinal (gut) microbiome (8–10).”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [8]
In the citing paper
“their gene count that exceeds the human genome’s gene count by ~100-fold and enables diverse metabolic programming”
From The microbiome and human cancer (2021) · cites this paper as [31]
In the citing paper
“the number of microbes that inhabit the human body (roughly equal to the number of human cells)”
From The microbiome and human cancer (2021) · cites this paper as [31]
In the citing paper
“their effects on host immune system development and activity, including antitumor immunosurveillance (27–31).”
From The microbiome and human cancer (2021) · cites this paper as [31]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Self-citationMetabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Research works printed but not linked: 1
- 10.1111/j.1572-0241.2000.01860.x · doi:10.1111/j.1572-0241.2000.01860.x · Paper page
Cited by
Items 101–200 of 1,001
von Martels, J. Z. H., Sadaghian Sadabad, M., Bourgonje, A. R., Blokzijl, T., Dijkstra, G., Faber, K. N., & Harmsen, H. J. M. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.01.001 · Cited by 184
The Microbiome and Genitourinary Cancer: A Collaborative Review
Markowski, M. C., Boorjian, S. A., Burton, J. P., Hahn, N. M., Ingersoll, M. A., Maleki Vareki, S., Pal, S. K., & Sfanos, K. S. (2019) · European Urology · doi:10.1016/j.eururo.2018.12.043 · Cited by 182
Curty, G., de Carvalho, P. S., & Soares, M. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010222 · Cited by 180
“Changes in human microbiome homeostasis may impair the symbiotic relationship between host and microorganisms, promote physiological changes in the individual, and lead to the development of diseases such as cancer [27].”
BackgroundColorectal Cancers: An Update on Their Molecular Pathology
Inamura, K. (2018) · Cancers · doi:10.3390/cancers10010026 · Cited by 174
Miller, G. E., Engen, P. A., Gillevet, P. M., Shaikh, M., Sikaroodi, M., Forsyth, C. B., Mutlu, E., & Keshavarzian, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0148952 · Cited by 171
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Derosa, L., Routy, B., Desilets, A., Daillère, R., Terrisse, S., Kroemer, G., & Zitvogel, L. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0236 · Cited by 170
Gori, S., Inno, A., Belluomini, L., Bocus, P., Bisoffi, Z., Russo, A., & Arcaro, G. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.09.003 · Cited by 165
Gut microbiota influence tumor development and Alter interactions with the human immune system
Ge, Y., Wang, X., Guo, Y., Yan, J., Abuduwaili, A., Aximujiang, K., Yan, J., & Wu, M. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01845-6 · Cited by 165
Flygare, S., Simmon, K., Miller, C., Qiao, Y., Kennedy, B., Di Sera, T., Graf, E. H., Tardif, K. D., Kapusta, A., Rynearson, S., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-0969-1 · Cited by 164
Microbiota-Derived Metabolites in Tumor Progression and Metastasis
Rossi, T., Vergara, D., Fanini, F., Maffia, M., Bravaccini, S., & Pirini, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165786 · Cited by 161
“Garret summarized this complexity, defining three major ways of microbiota contribution to carcinogenesis: (i) modulating the balance between cell proliferation and death, (ii) steering the immune system, and (iii) influencing the metabolism of the host [4].”
BackgroundGut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 159
Kell, D. B., & Pretorius, E. (2015) · Integrative Biology · doi:10.1039/c5ib00158g · Cited by 160
Nené, N. R., Reisel, D., Leimbach, A., Franchi, D., Jones, A., Evans, I., Knapp, S., Ryan, A., Ghazali, S., Timms, J. F., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30340-7 · Cited by 156
Shen, M., Chen, B., Yang, J., Wang, J., Zhu, D., Meng, Q., & Zhang, L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00318 · Cited by 172
Zheng, D., Deng, W., Song, W., Wu, C., Liu, J., Hong, S., Zhuang, Z., Cheng, H. L., Sun, Z., & Zhang, X. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00807-9 · Cited by 166
Transforming Cancer Prevention through Precision Medicine and Immune-oncology
Kensler, T. W., Spira, A., Garber, J. E., Szabo, E., Lee, J. J., Dong, Z., Dannenberg, A. J., Hait, W. N., Blackburn, E., Davidson, N. E., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0406 · Cited by 154
Piyathilake, C. J., Ollberding, N. J., Kumar, R., Macaluso, M., Alvarez, R. D., & Morrow, C. D. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0350 · Cited by 154
Impact of Preservation Method and 16S rRNA Hypervariable Region on Gut Microbiota Profiling
Chen, Z., Hui, P. C., Hui, M., Yeoh, Y. K., Wong, P. Y., Chan, M. C. W., Wong, M. C. S., Ng, S. C., Chan, F. K. L., & Chan, P. K. S. (2019) · mSystems · doi:10.1128/msystems.00271-18 · Cited by 154
“associated microbes reside, indicate that the disruption of microorganisms and their abundances could be linked to a number of diseases, such as carcinogenesis (3), cardiovascular disease (4), diabetes (5), hypertension (6), inflammatory bowel disease (7), and obesity (8).”
BackgroundIntratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma
Chai, X., Wang, J., Li, H., Gao, C., Li, S., Wei, C., Huang, J., Tian, Y., Yuan, J., Lu, J., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2022.2156255 · Cited by 152
Microbiota at the crossroads of autoimmunity
Shamriz, O., Mizrahi, H., Werbner, M., Shoenfeld, Y., Avni, O., & Koren, O. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.07.012 · Cited by 175
Increased gut permeability in cancer cachexia: mechanisms and clinical relevance
Bindels, L. B., Neyrinck, A. M., Loumaye, A., Catry, E., Walgrave, H., Cherbuy, C., Leclercq, S., Van Hul, M., Plovier, H., Pachikian, B., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24804 · Cited by 147
“Links between gut microbiota and cancer have been studied for years [14, 15], but it is only recently that the existence of a crosstalk between gut microbiota and metabolic alterations -including cachexia- occurring during cancer has been proposed based on three main experimental observations.”
BackgroundGuo, W., Zhang, Y., Guo, S., Mei, Z., Liao, H., Dong, H., Wu, K., Ye, H., Zhang, Y., Zhu, Y., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02557-5 · Cited by 145
Carcinogenesis and therapeutics: the microbiota perspective
Tsilimigras, M. C. B., Fodor, A., & Jobin, C. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.8 · Cited by 144
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy
Estrela, J. M., Mena, S., Obrador, E., Benlloch, M., Castellano, G., Palmer, R. S., & Dellinger, R. W. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01026 · Cited by 152
Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma
Lamont, R. J., Fitzsimonds, Z. R., Wang, H., & Gao, S. (2022) · Periodontology 2000 · doi:10.1111/prd.12425 · Cited by 160
Gao, J., Zhang, Y., Gerhard, M., Mejías‐Luque, R., Zhang, L., Vieth, M. W., Ma, J., Bajbouj, M., Suchánek, Š., Liu, W., et al. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00202 · Cited by 144
The Gut Microbiome Regulates Psychological-Stress-Induced Inflammation
Xu, C., Lee, S. K., Zhang, D., & Frenette, P. S. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.025 · Cited by 134
“, 2012), playing a role in cancer, inflammatory bowel diseases and other conditions (Garrett, 2015; Ni et al., 2017).”
BackgroundThe microbiome and its potential as a cancer preventive intervention
Bultman, S. J. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.001 · Cited by 134
The Gut Microbiome in Pancreatic Disease
Akshintala, V. S., Talukdar, R., Singh, V. K., & Goggins, M. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.045 · Cited by 131
Precancer Atlas to Drive Precision Prevention Trials
Spira, A., Yurgelun, M. B., Alexandrov, L., Rao, A., Bejar, R., Polyak, K., Giannakis, M., Shilatifard, A., Finn, O. J., Dhodapkar, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2346 · Cited by 129
The Microbiome as a Component of the Tumor Microenvironment
Kovàcs, T., Mikó, E., Ujlaki, G., Sári, Z., & Bai, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35727-6_10 · Cited by 140
The female urinary microbiota, urinary health and common urinary disorders
Brubaker, L. T., & Wolfe, A. J. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2016.11.62 · Cited by 151
Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies
Rahman, M. M., Islam, M. R., Shohag, S., Ahasan, M. T., Sarkar, N., Khan, H., Hasan, A. M., Cavalu, S. D., & Rauf, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112898 · Cited by 142
Microbial transmission in the social microbiome and host health and disease
Sarkar, A., McInroy, C. J. A., Harty, S., Raulo, A., Ibata, N. G. O., Valles‐Colomer, M., Johnson, K. V. ‐., Brito, I., Henrich, J., Archie, E. A., et al. (2024) · Cell · doi:10.1016/j.cell.2023.12.014 · Cited by 151
Whisner, C. M., & Aktipis, A. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-0257-2 · Cited by 139
Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients
Zhao, F., An, R., Wang, L., Shan, J., & Wang, X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.725284 · Cited by 139
“Intestinal flora such as Fusobacterium nucleatum, Escherichia coli, Bacteroides fragilis and Aspergillus have been associated with carcinogenesis (Schwabe and Jobin, 2013; Garrett, 2015).”
BackgroundPeriodontal Health and Disease in the Context of Systemic Diseases
Isola, G., Santonocito, S., Lupi, S. M., Polizzi, A., Sclafani, R., Patini, R., & Marchetti, E. (2023) · Mediators of Inflammation · doi:10.1155/2023/9720947 · Cited by 170
“Currently, the connection between the oral bio fi lm and the up-and downregulation of prooncogenic pathways is poorly understood [85, 86, 92].”
BackgroundInflammation in cancer: therapeutic opportunities from new insights
Xie, Y., Liu, F., Wu, Y., Zhu, Y., Jiang, Y., Wu, Q., Dong, Z., & Liu, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02243-8 · Cited by 167
Measuring the diversity of the human microbiota with targeted next-generation sequencing
Finotello, F., Mastrorilli, E., & Di Camillo, B. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw119 · Cited by 123
Mucosa-associated microbiota signature in colorectal cancer
Gao, R., Kong, C., Huang, L., Li, H., Qu, X., Liu, Z., Lan, P., Wang, J., & Qin, H. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3026-4 · Cited by 131
Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients
Chen, Y., Ho, H. J., Tseng, C., Lai, Z., Shieh, J., & Wu, C. (2018) · Experimental Dermatology · doi:10.1111/exd.13786 · Cited by 124
Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications
Baba, Y., Iwatsuki, M., Yoshida, N., Watanabe, M., & Baba, H. (2017) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12014 · Cited by 123
Cancer metastasis: Molecular mechanisms and clinical perspectives
Khan, S. U., Fatima, K., Malik, F. A., Kalkavan, H., & Wani, A. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108522 · Cited by 132
Yao, K., Yao, Y., Shen, X., Lu, C., & Guo, Q. (2019) · BMC Oral Health · doi:10.1186/s12903-019-0716-6 · Cited by 141
Queirolo, P., Boutros, A., Tanda, E. T., Spagnolo, F., & Quaglino, P. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.001 · Cited by 126
Costa, D. A., Nobre, J. G., Batista, M. V., Ribeiro, C., Callé, C., Cortés, A., Marhold, M., Negreiros, I., Borralho, P., Brito, M., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.584332 · Cited by 140
“Better understanding about this nested and complex interplay between the host and its own microbes has provided important data about how gut microbiota plays a crucial role on the development, treatment and prognosis of cancer, in particularly BC (Garrett, 2015; Roy and Trinchieri, 2017; Banerjee et al., 2018; Dart, 2…”
BackgroundInfluentialIncreased cancer risk in patients with periodontitis
Dızdar, Ö., Hayran, M., Güven, D. C., Yılmaz, B. T., Taheri, S., Akman, A. C., Bılgın, E., Hüseyin, B., & Berker, E. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1354829 · Cited by 132
Tao, J., Li, S., Gan, R.-Y., Zhao, C.-N., Meng, X., & Li, H.-B. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1555789 · Cited by 119
“In addition, gut microbiota can interact with anticancer drugs, influencing the clinical effects of chemotherapy and immunotherapy for cancers (Garrett 2015).”
BackgroundAlterations of fecal bacterial communities in patients with lung cancer.
Zhang, W., Zhao, S., Luo, J., Dong, X., Hao, Y., Li, H., Shan, L., Zhou, Y., Shi, H., Zhang, Z.-Y., et al. (2018) · Europe PMC (PubMed Central) · Cited by 141
Microbiota and prostate cancer
Rizzo, A., Santoni, M., Mollica, V., Fiorentino, M., Brandi, G., & Massari, F. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.09.007 · Cited by 130
Microbiota in cancer development and treatment
Raza, M. H., Gul, K., Arshad, A., Riaz, N., Waheed, U., Rauf, A., Aldakheel, F. M., Alduraywish, S. A., Rehman, M. U., Abdullah, M., et al. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2816-0 · Cited by 129
Larsen, E. S., Joensen, U. N., Poulsen, A. M., Goletti, D., & Johansen, I. S. (2019) · Apmis · doi:10.1111/apm.13011 · Cited by 113
“However, the microorganisms are also involved in the pathogenesis of cancers, including gastric cancer, colon cancer and cervical cancer (61).”
BackgroundKerry, R. G., Ukhurebor, K. E., Kumari, S., Maurya, G. K., Patra, S., Panigrahi, B., Majhi, S., Rout, J. R., Rodríguez-Torres, M. D. P., Das, G., et al. (2021) · Biomaterials Science · doi:10.1039/d0bm02164d · Cited by 128
Newman, T. M., Shively, C. A., Register, T. C., Appt, S. E., Yadav, H., Colwell, R. R., Fanelli, B. C., Dadlani, M., Graubics, K., Nguyen, U. T., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01069-y · Cited by 126
Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle
García-Castillo, V., Sanhueza, E., McNerney, E. M., Oñate, S. A., & García, A. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000371 · Cited by 125
Gunathilake, M. N., Lee, J., Choi, I. J., Kim, Y., Ahn, Y., Park, C., & Kim, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-50054-x · Cited by 149
Invited Review: From nose to gut – the role of the microbiome in neurological disease
Bell, J. S., Spencer, J. I., Yates, R. L., Yee, S. A., Jacobs, B. M., & DeLuca, G. C. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12520 · Cited by 110
Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma
Chen, M., Lu, M., Hsieh, C., & Chen, W. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00573-x · Cited by 119
Quinones are growth factors for the human gut microbiota
Fenn, K., Strandwitz, P., Stewart, E. J., Dimise, E., Rubin, S., Gurubacharya, S., Clardy, J., & Lewis, K. (2017) · Microbiome · doi:10.1186/s40168-017-0380-5 · Cited by 108
DT-MIL: Deformable Transformer for Multi-instance Learning on Histopathological Image
Li, H., Yang, F., Zhao, Y., Xing, X., Zhang, J., Gao, M., Huang, J., Wang, L., & Yao, J. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-87237-3_20 · Cited by 108
Microbiome and Cervical Cancer
Castanheira, C. P., Sallas, M. L., Nunes, R. A. L., Lorenzi, N. P. C., & Termini, L. (2020) · Pathobiology · doi:10.1159/000511477 · Cited by 120
Park, H. E., Kim, J. H., Cho, N., Lee, H. S., & Kang, G. H. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2171-6 · Cited by 112
The significance of microbiome in personalized medicine
Behrouzi, A., Nafari, A. H., & Siadat, S. D. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0232-y · Cited by 120
“nucleatum), which is found to be abundant in colorectal cancer [23].”
BackgroundMemmott, R. M., Wolfe, A. R., Carbone, D. P., & Williams, T. M. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.03.017 · Cited by 118
Sztukowska, M. N., Ojo, A., Ahmed, S., Carenbauer, A. L., Wang, Q., Shumway, B., Jenkinson, H. F., Wang, H., Darling, D. S., & Lamont, R. J. (2016) · Cellular Microbiology · doi:10.1111/cmi.12554 · Cited by 102
Tarallo, S., Ferrero, G., Gallo, G., Francavilla, A., Clerico, G. F., Luc, A. R., Manghi, P., Thomas, A. M., Vineis, P., Segata, N., et al. (2019) · mSystems · doi:10.1128/msystems.00289-19 · Cited by 111
“the oncobiome relates to microbes that can cause cell transformation by affecting genome stability, resistance to cell death, and proliferative signaling (3).”
BackgroundMicrobes and Cancer: Friends or Faux?
Azevedo, M. M., Pina‐Vaz, C., & Baltazar, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093115 · Cited by 104
“According to Garrett [121], microbiota could contribute to carcinogenesis by altering the balance between the host cell proliferation and death (by changing the immune system and influencing metabolism).”
BackgroundChen, C., Wang, Z., Wang, J., Ding, C., Sun, C., Liu, P., Xu, X., Liu, Y., Chen, B., & Gu, B. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-19-590 · Cited by 105
“Discussion The human microbiota is known to play a critical role in the development and progression of cancers by affecting host inflammation, immunity and metabolism (23,24).”
BackgroundInfluence of Intratumor Microbiome on Clinical Outcome and Immune Processes in Prostate Cancer
Ma, J., Gnanasekar, A., Lee, A., Li, W. T., Haas, M., Wang-Rodriguez, J., Chang, E. Y., Rajasekaran, M., & Ongkeko, W. M. (2020) · Cancers · doi:10.3390/cancers12092524 · Cited by 100
Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer
Kohi, S., Macgregor‐Das, A. M., Dbouk, M. H., Yoshida, T., Chuidian, M., Abe, T., Borges, M. W., Lennon, A. M., Shin, E. J., Canto, M. I., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.11.006 · Cited by 111
Identification of low abundance microbiome in clinical samples using whole genome sequencing
Zhang, C., Cleveland, K., Schnoll-Sussman, F., McClure, B., Bigg, M., Thakkar, P., Schultz, N., Shah, M. A., & Betel, D. (2015) · Genome Biology · doi:10.1186/s13059-015-0821-z · Cited by 96
The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics
Bajic, P., Wolfe, A. J., & Gupta, G. N. (2019) · Urology · doi:10.1016/j.urology.2018.12.034 · Cited by 100
Zhang, N., Yang, X., Piao, M., Xun, Z., Wang, Y., Ning, C., Zhang, L., Zhang, L., Wang, S., Wang, S., et al. (2024) · Biomarker Research · doi:10.1186/s40364-023-00535-z · Cited by 115
“Commensal microorganisms, collectively known as the microbiota, have been shown to impact human immune responses in both healthy and diseased conditions [89, 90].”
BackgroundYuan, B., Zhu, Q., Guo, N., Zheng, S.-J., Wang, Y., Wang, J., Xu, J., Liu, S., He, K. F., Hu, T., et al. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b05355 · Cited by 99
Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Soto‐Pantoja, D. R., Gaber, M. K., Arnone, A. A., Bronson, S. M., Cruz‐Diaz, N., Wilson, A. S., Clear, K. Y. J., Ramirez, M. U., Kucera, G. L., Levine, E. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2983 · Cited by 102
Oral delivery of bacteria: Basic principles and biomedical applications
Li, S., Jiang, W., Zheng, C., Shao, D., Liu, Y., Huang, S., Han, J., Ding, J., Tao, Y., & Li, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.011 · Cited by 97
The relationships between the gut microbiota and its metabolites with thyroid diseases
Jiang, W., Lu, G., Gao, D., Lv, Z., & Li, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.943408 · Cited by 114
“The microbiota and its metabolites are important endogenous factors that can influence the development of various cancers (26).”
BackgroundWolf, A., Moissl‐Eichinger, C., Perras, A., Koskinen, K., Tomazic, P. V., & Thurnher, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-06361-2 · Cited by 105
The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease
Raj, D., Tomar, B., Lahiri, A., & Mulay, S. R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104617 · Cited by 104
Chen, L., Zhou, X., Wang, Y., Wang, D., Ke, Y., & Zeng, X. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100096 · Cited by 100
Mahdy, M. S., Azmy, A. F., Dishisha, T., Mohamed, W. R., Ahmed, K. A., Hassan, A. M., Aidy, S. E., & EL-Gendy, A. O. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02791-3 · Cited by 100
“Toxins and metabolites from translocated bacteria can influence the DNA stability, cell cycle, cell proliferation, as well as tumor initiation and development [3, 16].”
BackgroundInfluentialThe impact of the intestinal microbiota in therapeutic responses against cancer
Goubet, A., Daillère, R., Routy, B., Derosa, L., Roberti, P. M., & Zitvogel, L. (2018) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2018.03.004 · Cited by 100
Of microbes and minds: A narrative review on the second brain aging
Calvani, R., Picca, A., Lo Monaco, M. R., Landi, F., Bernabei, R., & Marzetti, E. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00053 · Cited by 92
Müller, H., Dagher, G., Loibner, M., Stumptner, C., Kungl, P., & Zatloukal, K. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.12.004 · Cited by 99
Dong, J., Li, Y., Xiao, H., Zhang, S., Wang, B., Wang, H., Li, Y., Fan, S., & Cui, M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109886 · Cited by 101
The Crosstalk between Microbiome and Immune Response in Gastric Cancer
Nasr, R., Shamseddine, A. I., Mukherji, D., Nassar, F. J., & Temraz, S. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186586 · Cited by 99
“In normal “symbiosis”, the role of the gut microbiome is to support the host’s mucosal immune response, energy metabolism, pathogen elimination, and prevent cancer development [1].”
BackgroundOral microbiome, periodontitis and risk of head and neck cancer
Galvão-Moreira, L. V., & da Cruz, M. C. F. N. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.11.013 · Cited by 100
Sommer, F., & Bäckhed, F. (2016) · BioEssays · doi:10.1002/bies.201500151 · Cited by 91
Busnelli, M., Manzini, S., & Chiesa, G. (2019) · Nutrients · doi:10.3390/nu12010079 · Cited by 98
“Important y, the gut mic obiota not only contributes to host physiology, but, on the other ide, alterations in the distribution f the species that make up the intestinal microbio a (dysbiosis) can predispose to a variety of chronic dise ses, including inflammatory bowel disease [41], gastric ulcers 4 non-alcohol fatty…”
BackgroundThe Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus
Crăciun, C.-I., Neag, M. A., Cătinean, A., Mitre, A. O., Rusu, A., Bala, C. G., Román, G., Buzoianu, A. D., Muntean, D. M., & Craciun, A. E. (2022) · Biomedicines · doi:10.3390/biomedicines10020308 · Cited by 105
A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma
Yang, J., He, Q., Lü, F., Chen, K., Ni, Z., Wang, H., Zhou, C., Zhang, Y., Chen, B., Bo, Z., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2201159 · Cited by 99
Lawler, M., Alsina, D., Adams, R., Anderson, A. S., Brown, G., Fearnhead, N. S., Fenwick, S. W., Halloran, S. P., Hochhauser, D., Hull, M. A., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-315333 · Cited by 99
Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders
Pagliari, D., Saviano, A., Newton, E. E., Serricchio, M. L., Dal Lago, A. A., Gasbarrini, A., & Cianci, R. (2018) · Mediators of Inflammation · doi:10.1155/2018/7946431 · Cited by 89
MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities
Pedroza‐Torres, A., Romero-Cordoba, S. L., Justo-Garrido, M., Salido-Guadarrama, I., Rodríguez‐Bautista, R., Montaño, S., Muñiz-Mendoza, R., Arriaga-Canon, C., Fragoso‐Ontiveros, V., Álvarez-Gómez, R. M., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01404 · Cited by 97
Zeng, J., Zhang, G., Chen, C., Li, K., Wen, Y., Zhao, J., & Wu, P. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.555508 · Cited by 91
“For example, the intestinal microbiota may promote local inflammation and development of gastrointestinal cancers (Elinav et al., 2013; Garrett, 2015).”
BackgroundJia, W., Rajani, C., Kaddurah‐Daouk, R., & Li, H. (2020) · Medicinal Research Reviews · doi:10.1002/med.21653 · Cited by 88
“Certain gut microbiota such as Clostridia IV, XIVa, and Bacteroides fragilis can bind the gut epithelium directly or produce SCFAs that regulate the balance of T‐cells differentiation into Treg cells or Th17 cells.(44) These findings provide an additional interaction between the gut, BAs and loss/maintenance of barrie…”
BackgroundAdapting Cancer Immunotherapy Models for the Real World
Klevorn, L. E., & Teague, R. M. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.03.010 · Cited by 88
Host-Microbiome Interaction in Lung Cancer
Dong, Q., Chen, E. S., Zhao, C. N., & Jin, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.679829 · Cited by 102
“Interestingly, while the gut microbiota is found to promote local inflammation and development of gastrointestinal cancers (7, 51), it seems to exert an opposing effect on transplanted tumors at distal sites by priming the host immune system and”
BackgroundImpact of a 3-Months Vegetarian Diet on the Gut Microbiota and Immune Repertoire
Zhang, C., Björkman, A., Cai, K., Liu, G., Wang, C., Li, Y., Xia, H., Sun, L., Kristiansen, K., Wang, J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00908 · Cited by 87
Melnik, A. V., da Silva, R. R., Hyde, E. R., Aksenov, A. A., Vargas, F., Bouslimani, A., Protsyuk, I., Jarmusch, A. K., Tripathi, A., Alexandrov, T., et al. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01381 · Cited by 87
Metadata
- Authors
- Garrett, W. S.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Garrett, Wendy S.
- ORCID
- Garrett, Wendy S.
- Venue
- Science
- Published
- 2015-04-03
- Volume
- 348
- Issue
- 6230
- Pages
- 80-86
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5535753
- OpenAlex
- W2073924079
- Cited by
- 1,404
- References
- 119
- Citations by year
- 2026: 145 · 2025: 169 · 2024: 169 · 2023: 151 · 2022: 162 · 2021: 141 · 2020: 127 · 2019: 106 · 2018: 77 · 2017: 68 · 2016: 58 · 2015: 29
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (R01CA154426)
- Burroughs Wellcome Career in Medical Sciences Award
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- gut microbiota, cancer susceptibility, carcinogenesis, host-microbe interactions, cancer therapy response, cancer diagnosis
- MeSH terms
- Humans, Immunotherapy, Neoplasms, Carcinogenesis, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.